In human diploid fibroblasts (HDFs), expression of lamina-associated polypeptide 2 α (LAP2α) upon entry and exit from G0 is tightly correlated with phosphorylation and subnuclear localization of retinoblastoma protein (Rb). Phosphoisoforms of Rb and LAP2α are down-regulated in G0. Although RbS780 phosphoform and LAP2α are up-regulated upon reentry into G1 and colocalize in the nucleoplasm, RbS795 migrates between nucleoplasmic and speckle compartments. In HDFs, which are null for lamins A/C, LAP2α is mislocalized within nuclear aggregates, and this is correlated with cell cycle arrest and accumulation of Rb within speckles. Nuclear retention of nucleoplasmic Rb during G1 phase but not of speckle-associated Rb depends on lamin A/C. siRNA knock down of LAP2α or lamin A/C in HDFs leads to accumulation of Rb in speckles and G1 arrest, probably because of activation of a cell cycle checkpoint. Our results suggest that LAP2α and lamin A/C are involved in controlling Rb localization and phosphorylation, and a lack or mislocalization of either protein leads to cell cycle arrest in HDFs.
Skip Nav Destination
Article navigation
15 January 2007
Article|
January 16 2007
Nucleoplasmic LAP2α–lamin A complexes are required to maintain a proliferative state in human fibroblasts
Vanja Pekovic,
Vanja Pekovic
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Search for other works by this author on:
Jens Harborth,
Jens Harborth
2Alnylam Pharmaceuticals, Inc., Bioanalytics and Preclinical, Cambridge, MA 02142
Search for other works by this author on:
Jos L.V. Broers,
Jos L.V. Broers
3Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, and Research Institute Growth and Development, University of Maastricht, Maastricht, Netherlands
Search for other works by this author on:
Frans C.S. Ramaekers,
Frans C.S. Ramaekers
3Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, and Research Institute Growth and Development, University of Maastricht, Maastricht, Netherlands
Search for other works by this author on:
Baziel van Engelen,
Baziel van Engelen
4Neuromuscular Centre Nijmegen, Institute of Neurology, University Medical Centre, Nijmegen, Netherlands
Search for other works by this author on:
Martin Lammens,
Martin Lammens
4Neuromuscular Centre Nijmegen, Institute of Neurology, University Medical Centre, Nijmegen, Netherlands
Search for other works by this author on:
Thomas von Zglinicki,
Thomas von Zglinicki
5Henry Wellcome Laboratory for Biogerontology Research, University of Newcastle, Newcastle General Hospital, Newcastle-upon-Tyne NE4 6BE, England, UK
Search for other works by this author on:
Roland Foisner,
Roland Foisner
6Max F. Perutz Laboratories, Medical University Vienna, 1030 Vienna, Austria
Search for other works by this author on:
Chris Hutchison,
Chris Hutchison
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Search for other works by this author on:
Ewa Markiewicz
Ewa Markiewicz
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Search for other works by this author on:
Vanja Pekovic
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Jens Harborth
2Alnylam Pharmaceuticals, Inc., Bioanalytics and Preclinical, Cambridge, MA 02142
Jos L.V. Broers
3Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, and Research Institute Growth and Development, University of Maastricht, Maastricht, Netherlands
Frans C.S. Ramaekers
3Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, and Research Institute Growth and Development, University of Maastricht, Maastricht, Netherlands
Baziel van Engelen
4Neuromuscular Centre Nijmegen, Institute of Neurology, University Medical Centre, Nijmegen, Netherlands
Martin Lammens
4Neuromuscular Centre Nijmegen, Institute of Neurology, University Medical Centre, Nijmegen, Netherlands
Thomas von Zglinicki
5Henry Wellcome Laboratory for Biogerontology Research, University of Newcastle, Newcastle General Hospital, Newcastle-upon-Tyne NE4 6BE, England, UK
Roland Foisner
6Max F. Perutz Laboratories, Medical University Vienna, 1030 Vienna, Austria
Chris Hutchison
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Ewa Markiewicz
1School of Biological and Biomedical Sciences, University of Durham, Durham DH1 3LE, England, UK
Correspondence to Chris Hutchison: [email protected]
Abbreviations used in this paper: HDF, human diploid fibroblast; LAP2, lamina-associated polypeptide 2; MEF, mouse embryonic fibroblast; NCS, newborn calf serum; NE, nuclear envelope; Rb, retinoblastoma protein.
Received:
June 29 2006
Accepted:
December 15 2006
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2007
J Cell Biol (2007) 176 (2): 163–172.
Article history
Received:
June 29 2006
Accepted:
December 15 2006
Citation
Vanja Pekovic, Jens Harborth, Jos L.V. Broers, Frans C.S. Ramaekers, Baziel van Engelen, Martin Lammens, Thomas von Zglinicki, Roland Foisner, Chris Hutchison, Ewa Markiewicz; Nucleoplasmic LAP2α–lamin A complexes are required to maintain a proliferative state in human fibroblasts . J Cell Biol 15 January 2007; 176 (2): 163–172. doi: https://doi.org/10.1083/jcb.200606139
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement